Abdel Aal, H <br/><br/>
Clinical experience with 0.05% halometasone/1% triclosan cream in the treatment of acute infected and infection-prone eczema in Egypt.  [electronic resource] 

 -  The Journal of international medical research   
 - 383-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0300-0605 
<br/><br/><label>Standard No.: </label>10.1177/030006058701500609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Administration, Topical<br/>Adolescent<br/>Adult<br/>Anti-Inflammatory Agents--administration & dosage<br/>Betamethasone--administration & dosage<br/>Child<br/>Child, Preschool<br/>Clinical Trials as Topic<br/>Drug Combinations<br/>Eczema--drug therapy<br/>Egypt<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Ointments<br/>Phenyl Ethers--administration & dosage<br/>Skin Diseases, Infectious--drug therapy<br/>Time Factors<br/>Triclosan--administration & dosage